Curve Therapeutics
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Delta House, Enterprise Road, Southampto...Website
www.curvetx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Curve Therapeutics
Curve Therapeutics specializes in drug discovery using its innovative mammalian cell-based Microcycle platform to develop cyclic peptide and small molecule drugs targeting intracellular diseases, particularly in cancer, immunology, and inflammation. Their unique Microcycles are compact, rigid macrocycles that function like small molecules, enabling the discovery of novel and more effective therapeutics. The company aims to transform patient lives by addressing high-priority intracellular disease targets that traditional methods have struggled to reach. Curve Therapeutics is committed to pioneering approaches in the treatment of challenging diseases through its advanced drug discovery techniques.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Curve Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Curve Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Curve Therapeutics
Funding: Get notified immidiatlly once Curve Therapeutics has new funding data
Earning: See what the market has to say on Curve Therapeutics recently announced quarterly report
Check if Curve Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Curve Therapeutics launches new products
Click to see if Curve Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Curve Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Curve Therapeutics
Find 2 more new buyers
Compare Similar Companies to Curve Therapeutics
Compare insights from companies similar to Curve Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Curve Therapeutics
<$5M
11-50
Private
$51.3M
2019
N/A
Company Profile Activity
Activity Insights
Curve Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Curve Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Curve Therapeutics.
Curve Therapeutics financials insights
Gather financial insights about Curve Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$51.3M
Curve Therapeutics Tech Stack
A closer look at the technologies used by Curve Therapeutics
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Funding
Curve Therapeutics News & Media
Curve Therapeutics continues to enhance leadership team with appointment of Rab Prinjha as Chief R&D Officer
Deep expertise in leading drug discovery programs across oncology, neuroscience and epigenetics Will drive advancement of Curve's rich pipeline of first-in-class therapeutic assets Builds on recent leadership team appointments, including Andre Hoekema as Chair of the Board SOUTHAMPTON,...Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board
Dr Hoekema brings over four decades of successful biotech and life science leadership Dr Cora Griffin appointed to head up business development, follows recent appointment of Simon Jones as CFO/COO New hires to accelerate ambition to turbocharge the discovery platform, develop innovative...Simon joins as CFO and COO of Southampton's Curve Therapeutics
Southampton-based biotechnology Curve Therapeutics has announced the appointment of Simon Jones as both chief financial officer (CFO) and chief operating officer (COO). Simon brings more than 20 years’...Curve Therapeutics strengthens Leadership Team with appointment of experienced biotech executive Simon Jones
Accomplished CFO and COO with proven track record in the biotech and pharmaceutical industry Strengthens Curve's Leadership Team following £40.5 million Series A financing SOUTHAMPTON, England, July 9, 2024 /PRNewswire/ -- Curve Therapeutics ("Curve" or the "Company"), a private...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Curve Therapeutics
Sign Up For FreeTo access detailed company insights
Curve Therapeutics specializes in drug discovery using its innovative mammalian cell-based Microcycle platform to develop cyclic peptide and small molecule drugs targeting intracellular diseases, particularly in cancer, immunology, and inflammation. Their unique Microcycles are compact, rigid macrocycles that function like small molecules, enabling... Read More
